Pfizer’s recent decision to withdraw Oxbryta (voxelotor) from global markets feels like a devastating blow for many people with sickle cell disease. Oxbryta’s conditional approval in 2019 by the U.S.
Pfizer is voluntarily withdrawing its sickle cell disease (SCD) therapy Oxbryta from all world markets after finding an "imbalance" in deaths in its clinical trials programme. It's a blow to the ...
After hours: October 17 at 4:12 PM EDT Loading Chart for ICLR ...
We read every piece of feedback, and take your input very seriously.
The leading Indian education consultancy organization Global Arcus Limited has sent nine students from Papua New Guinea to India this morning (October 15) to pursue their degrees in higher education.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback
